Amaç: Koronavirüs hastalığı-2019 [coronavirus disease-2019 (COVID-19)] pandemi sürecindeki kapanmalar ve elektif ameliyatların durdurulması sebebiyle korneal kollajen çapraz bağlama (KÇB) tedavisi ertelenen hastaların keratokonus progresyonunu değerlendirmektir. Gereç ve Yöntemler: Pandemi sürecinde KÇB tedavisi ertelenen 29 hastanın 34 gözü çalışmaya dâhil edildi. Keratometri (K) değerleri, santral ve en ince korneal kalınlık değerleri, Sirius (CSO, Firenze, İtalya) Topografi cihazından elde edilerek, bekleme süresindeki değişiklikler analiz edildi. Kmaks değerinde 1D ve üzeri artış ile korneal kalınlıkta %2 ve üzeri incelme progresyon olarak değerlendirildi. Bulgular: Çalışmaya dâhil edilen 29 hastanın %20,6'sı kadın, yaş ortalaması 22,8±5,6 yıl ve ortalama bekleme süresi 109,78±48,62 gündü. Bekleme süresince ortalama Kmaks ve arka elevasyon değerlerindeki artış istatistiksel olarak anlamlı bulundu (p=0,023, p=0,002). Ortalama santral kornea kalınlığı ve en ince kornea kalınlığı istatistiksel olarak anlamlı bir şekilde azalmıştı (p<0,001 ve p=0,002). On altı (%47,1) hastada hastalığın ilerlediği tespit edildi. Hastaların %11,8'inde Kmaks değerinde 1D ve üzerinde artış vardı. Hastaların %38,2'sinde kornea %2 ve üzerinde incelmişti. Progresyon gösteren hastalar ile göstermeyen hastalar yaş ortalaması, görme keskinlikleri, sferik eş değerleri, KÇB gecikme süreleri açısından karşılaştırıldığında, progresyon göstermeyen hastaların yaş ortalaması 25±6,07 yıl iken, progresyon gösteren hastaların yaş ortalaması 20,81±5,15 yıl olarak bulundu, aradaki fark istatistiksel olarak anlamlıydı (p=0,047). Sonuç: COVID-19 pandemisi, keratokonus hastalarında KÇB uygulamalarında gecikmelere neden olabilmektedir. Keratokonus tedavisindeki 3 ay gibi kısa süren gecikmeler bile, özellikle genç hastalarda, hastalığın ciddi oranda ilerlemesine neden olabilmektedir. Bu nedenle KÇB tedavisi, progresyon riski yüksek olan genç keratokonus hastalarında elektif olarak değil, öncelikli tedavi olarak değerlendirilmelidir.
Anahtar Kelimeler: COVID-19; keratokonus; korneal kollajen çapraz bağlama; kornea topografisi
Objective: To investigate the progression of keratoconus patients whose corneal collagen cross-linking (CCL) treatment were delayed, due to lockdown and postponed elective surgery during coronavirus disease-2019 (COVID-19) pandemic. Material and Methods: Thirty four eyes of 29 keratoconus patients, whose CCL treatment were delayed during pandemic were recruited in the study. Keratometry (K) values, central and thinnest corneal thickness, were obtained from Sirius (CSO, Firenze, Italy) Topography device and the changes during the delay were analysed. 1D or more increase at Kmax or 2% or more thinning at cornel thickness was evaluated as progression. Results: A total of 29 patients, 20.6% were women, mean age was 22.8±5,6 years, average waiting time was 109.78±48.62 days. During the delay, increase at mean Kmax and posterior elevation (p=0.023, p=0,002), and decrease at mean central and thinnest corneal thicknesses (p<0,001 ve p=0.002) were statistically significant. Sixteen (47.1%) patients demonstrated progression either with 1D or more increase at Kmax (11.8), or more than 2% decrease at corneal thickness (38.2%). Patients with progression and without progression were compared according to average age, visual acuity, spherical equvalent, CCL delay time. The average age of patients without progresion was 25±6.07 years, while patients with progression was 20.81±5.15 years, and the difference was statistically significant (p=0.047). Conclusion: COVID-19 pandemic can cause delay at CCL treatment of keratoconus patients. Even short delays such as 3 months, especially for young patients, could cause severe progression of the disease. Though CCL should be evaluated as prior treatment not elective for younger patients those are at high risk for progression.
Keywords: COVID-19; keratoconus; corneal collagen crosslinking; corneal topography
- Rabinowitz YS. Keratoconus. Surv Ophthalmol. 1998;42(4):297-319. [Crossref] [PubMed]
- Kymes SM, Walline JJ, Zadnik K, Sterling J, Gordon MO; Collaborative Longitudinal Evaluation of Keratoconus Study Group. Changes in the quality-of-life of people with keratoconus. Am J Ophthalmol. 2008;145(4):611-7. [Crossref] [PubMed] [PMC]
- Kanellopoulos AJ, Asimellis G. Revisiting keratoconus diagnosis and progression classification based on evaluation of corneal asymmetry indices, derived from Scheimpflug imaging in keratoconic and suspect cases. Clin Ophthalmol. 2013;7:1539-48. [Crossref] [PubMed] [PMC]
- Shetty R, Kaweri L, Pahuja N, Nagaraja H, Wadia K, Jayadev C, et al. Current review and a simplified "five-point management algorithm" for keratoconus. Indian J Ophthalmol. 2015;63(1):46-53. [Crossref] [PubMed] [PMC]
- Pramanik S, Musch DC, Sutphin JE, Farjo AA. Extended long-term outcomes of penetrating keratoplasty for keratoconus. Ophthalmology. 2006;113(9):1633-8. [Crossref] [PubMed]
- Jabbarvand M, Hashemi H, Mohammadpour M, Khojasteh H, Khodaparast M, Hashemian H. Implantation of a complete intrastromal corneal ring at 2 different stromal depths in keratoconus. Cornea. 2014;33(2):141-4. [Crossref] [PubMed]
- Mohammadpour M, Heidari Z, Hashemi H. Updates on managements for keratoconus. J Curr Ophthalmol. 2017;30(2):110-24. [Crossref] [PubMed] [PMC]
- Rebenitsch RL, Kymes SM, Walline JJ, Gordon MO. The lifetime economic burden of keratoconus: a decision analysis using a markov model. Am J Ophthalmol. 2011;151(5):768-73.e2. [Crossref] [PubMed] [PMC]
- Pagano L, Gadhvi KA, Borroni D, Iselin KC, Vinciguerra R, Tzamalis A, et al. Bilateral keratoconus progression: immediate versus delayed sequential bilateral corneal cross-linking. J Refract Surg. 2020;36(8):552-6. [Crossref] [PubMed]
- Wollensak G, Spoerl E, Seiler T. Stress-strain measurements of human and porcine corneas after riboflavin-ultraviolet-A-induced cross-linking. J Cataract Refract Surg. 2003;29(9):1780-5. [Crossref] [PubMed]
- Raiskup F, Theuring A, Pillunat LE, Spoerl E. Corneal collagen crosslinking with riboflavin and ultraviolet-A light in progressive keratoconus: ten-year results. J Cataract Refract Surg. 2015;41(1):41-6. [Crossref] [PubMed]
- Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270-3. [PubMed] [PMC]
- Jee Y. WHO International Health Regulations Emergency Committee for the COVID-19 outbreak. Epidemiol Health. 2020;42:e2020013. [Crossref] [PubMed] [PMC]
- Romano MR, Montericcio A, Montalbano C, Raimondi R, Allegrini D, Ricciardelli G, et al. Facing COVID-19 in ophthalmology department. Curr Eye Res. 2020;45(6):653-8. [Crossref] [PubMed]
- Bal S, Chodosh J, Venkateswaran N. Impact of SARS-CoV-2 on ocular surface pathology and treatment practices: a review. Curr Ophthalmol Rep. 2021;9(3):77-82. [Crossref] [PubMed] [PMC]
- T.C. Sağlık Bakanlığı Sağlık Hizmetleri Genel Müdürlüğü. Elektif İşlemlerin Ertelenmesi ve Diğer Alınacak Tedbirler. 2020. Sayı: 14500235-403.99. [Link]
- Duncan JK, Belin MW, Borgstrom M. Assessing progression of keratoconus: novel tomographic determinants. Eye Vis (Lond). 2016;3:6. [Crossref] [PubMed] [PMC]
- American Academy of Ophthalmology [Internet]. © American Academy of Ophthalmology 2020. [Cited: May 1, 2020]. Recommendations for urgent and nonurgent patient care. San Francisco, CA, USA: American Academy of Ophthalmology; 2020. Available from: [Link]
- Guidance Document: Prioritisation of Ophthalmic Procedure. Cited: September 19, 2020. Available from: [Link]
- O'Brart DP, Chan E, Samaras K, Patel P, Shah SP. A randomised, prospective study to investigate the efficacy of riboflavin/ultraviolet A (370 nm) corneal collagen cross-linkage to halt the progression of keratoconus. Br J Ophthalmol. 2011;95(11):1519-24. [Crossref] [PubMed]
- Brown SE, Simmasalam R, Antonova N, Gadaria N, Asbell PA. Progression in keratoconus and the effect of corneal cross-linking on progression. Eye Contact Lens. 2014;40(6):331-8. [Crossref] [PubMed]
- Steinberg J, Bußmann N, Frings A, Katz T, Druchkiv V, Linke SJ. Quality of life in stable and progressive 'early-stage' keratoconus patients. Acta Ophthalmol. 2021;99(2):e196-e201. [Crossref] [PubMed]
- Mukhtar S, Ambati BK. Pediatric keratoconus: a review of the literature. Int Ophthalmol. 2018;38(5):2257-66. [Crossref] [PubMed] [PMC]
- Romano V, Vinciguerra R, Arbabi EM, Hicks N, Rosetta P, Vinciguerra P, et al. Progression of keratoconus in patients while awaiting corneal cross-linking: a prospective clinical study. J Refract Surg. 2018;34(3):177-80. [Crossref] [PubMed]
- Kato N, Negishi K, Sakai C, Tsubota K. Baseline factors predicting the need for corneal crosslinking in patients with keratoconus. PLoS One. 2020;15(4):e0231439. [Crossref] [PubMed] [PMC]
- Gomes JA, Tan D, Rapuano CJ, Belin MW, Ambrósio R Jr, Guell JL, et al; Group of Panelists for the Global Delphi Panel of Keratoconus and Ectatic Diseases. Global consensus on keratoconus and ectatic diseases. Cornea. 2015;34(4):359-69. [Crossref] [PubMed]
- Kumar M, Shetty R, Jayadev C, Dutta D. Comparability and repeatability of pachymetry in keratoconus using four noncontact techniques. Indian J Ophthalmol. 2015;63(9):722-7. [Crossref] [PubMed] [PMC]
- Doctor K, Vunnava KP, Shroff R, Kaweri L, Lalgudi VG, Gupta K, et al. Simplifying and understanding various topographic indices for keratoconus using Scheimpflug based topographers. Indian J Ophthalmol. 2020;68(12):2732-43. [Crossref] [PubMed] [PMC]
- Belin MW, Kundu G, Shetty N, Gupta K, Mullick R, Thakur P. ABCD: a new classification for keratoconus. Indian J Ophthalmol. 2020;68(12):2831-4. [Crossref] [PubMed] [PMC]
- Shah H, Pagano L, Vakharia A, Coco G, Gadhvi KA, Kaye SB, et al. Impact of COVID-19 on keratoconus patients waiting for corneal cross linking. Eur J Ophthalmol. 2021;31(6):3490-3. [Crossref] [PubMed]
- Wisse RPL, Simons RWP, van der Vossen MJB, Muijzer MB, Soeters N, Nuijts RMMA, et al. Clinical evaluation and validation of the dutch crosslinking for keratoconus score. JAMA Ophthalmol. 2019;137(6):610-6. [Crossref] [PubMed] [PMC]
- Ozalp O, Atalay E. Belin ABCD Progression display identifies keratoconus progression earlier than conventional metrics. Am J Ophthalmol. 2022;236:45-52. [Crossref] [PubMed]
- Shajari M, Steinwender G, Herrmann K, Kubiak KB, Pavlovic I, Plawetzki E, et al. Evaluation of keratoconus progression. Br J Ophthalmol. 2019;103(4):551-7. [Crossref] [PubMed]
- Savini G, Barboni P, Carbonelli M, Hoffer KJ. Repeatability of automatic measurements by a new Scheimpflug camera combined with Placido topography. J Cataract Refract Surg. 2011;37(10):1809-16. [Crossref] [PubMed]
- Shetty R, Arora V, Jayadev C, Nuijts RM, Kumar M, Puttaiah NK, et al. Repeatability and agreement of three Scheimpflug-based imaging systems for measuring anterior segment parameters in keratoconus. Invest Ophthalmol Vis Sci. 2014;55(8):5263-8. [Crossref] [PubMed]
.: İşlem Listesi